The Competition Commission of India (CCI) has dismissed a case of alleged cartelisation by Romsons Scientific & Surgical Industrial Pvt Ltd and BSN Medical Pvt Ltd and some of their officials. The regulator had directed the director general (DG) to carry out an investigation after the matter originated from a complaint alleging cartelisation by the firms in respect of a tender invited by AIIMS in 2016. The DG after taking into consideration the submissions of the parties, concluded that different parties, at different geographical locations with different cost of production and profit margins quoting identical rates, independently, would be too much of coincidence, which is difficult to believe. Accordingly, the DG concluded that the firms colluded and acted in contravention of provisions of the Competition Act. However, the CCI said that there is no evidence of any communications or meetings having taken place between the opposite parties (OPs) or any other arrangement indicating
If past experience is anything to go by, creating a new sectoral regulator for a specific industry is more likely to undermine the objective of combating anti-competitive conduct
Competition laws and Intellectual Property Rights (IPR) both encourage innovation and contribute to human progress, former RBI Governor D Subbarao said on Saturday
NITI Aayog Vice-Chairman Rajiv Kumar highlighted the need for the CCI to develop oversight capabilities on data-related businesses, so as to prevent the amassing of power in a single conglomerate
SC direction to the Competition Commission of India to investigate alleged predatory pricing by Uber disturbs the latter's policy position in market abuse cases
The plan is to come out with rules by the year-end for bringing e-commerce market players under the ambit of competition laws
The review panel must push for greater clarity on regulatory front, more CCI benches and expeditious disposal of cases, say experts
Legal experts share their insights on measures to make the competition law more effective